Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1017 of 5804
-
New pill shows promise for rare blood disorder in Long-Term trial
Disease control Not yet recruitingNTQ5082 capsules are a small molecule CFB inhibitor. This study is a multicenter, open-label study evaluating the long-term efficacy and safety of NTQ5082 capsules in the treatment of patients with paroxysmal nocturnal hemoglobinuria
Phase: PHASE3 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 17:40 UTC
-
Zapping nerves to tame stubborn high blood pressure and diabetes?
Disease control Not yet recruitingTo assess the safety and effectiveness of renal artery denervation with subsequent splanchnic nerves denervation via catheter-based radiofrequency ablation in improving blood pressure and glycemic control in patients with resistant hypertension and type 2 diabetes.
Phase: NA • Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
AI app aims to ease chemo side effects for breast cancer patients
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if an Arabic-language mobile application that uses artificial intelligence (AI) can help women with breast cancer during chemotherapy. The app is designed to give personalized support by reminding participants about their medications, t…
Phase: NA • Sponsor: Dena h. Al-Tameemi • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Could a repurposed drug boost brain recovery after severe injury?
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to determine if experimental drug treatment improves recovery after TBI as compared to a control (placebo) group. Changes in recovery will be measured throughout the study. The study drug listed below is approved by the U.S. Food and Drug Administrati…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New RNA test could spot brain tumors without surgery
Diagnosis Recruiting nowDiffuse gliomas are among the most common tumors of the central nervous system, with high morbidity and mortality and very limited therapeutic possibilities. The diffuse glioma are characterized by significant variability in terms of age at diagnosis, histological and molecular f…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Experimental CAR t therapy takes on tough leukemia
Disease control Recruiting nowThis is a Phase 1, open label, dose-escalation study to evaluate the safety, expansion, persistence, and preliminary clinical activity of lentivirally transduced autologous T cells expressing anti-CD64 chimeric antigen receptors (CAR) expressing tandem CD3ζ and 4-1BB (CD3ζ/4-1BB)…
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for rare bleeding disorder: coagadex trial targets AL amyloidosis
Disease control TerminatedThe purpose of this study is to evaluate the efficacy and safety of Coagadex in treating active bleeds and to manage peri-operative bleeding in participants with acquired factor X deficiency associated with AL amyloidosis.
Phase: PHASE3 • Sponsor: Kedrion S.p.A. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New study aims to reduce DKA risk for type 1 diabetes patients using SGLT2 inhibitors
Disease control Not yet recruitingThe purpose of this research is to see how well a special education plan using continuous ketone monitoring (DGK) works to lower the risk of a condition called diabetic ketoacidosis (DKA) in people with type 1 diabetes (T1D) taking SGLT2 inhibitors (a type of medication commonly …
Phase: PHASE2 • Sponsor: AdventHealth Translational Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for painful skin condition: drug trial launches
Disease control Not yet recruitingLichen planus (LP) is a common immune-mediated skin disease with a prevalence of 1-2% in the general population. It can present with a broad spectrum of clinical manifestations affecting primarily the skin (cutaneous LP \[CLP\]), the mucosae (mucosal LP \[MLP\]), hair follicles (…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Common sedative may stop dangerous heart rhythm after surgery
Prevention Not yet recruitingRecently, dexmedetomidine has been suggested as an alternative agent for sedation in tachyarrhythmias due to its antiarrhythmic properties through decreased catecholamine release, prolonged refractory period, and increased vagal tone. In addition, dexmedetomidine is a highly sele…
Phase: NA • Sponsor: Ain Shams University • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
New flu pill TRX-100 put to the test in human challenge trial
Disease control Not yet recruitingThis will be a randomized, double-blind, placebo-controlled proof of concept study to evaluate the prophylactic efficacy and safety of orally administered TRX-100 in healthy adults challenged with influenza A/France/759/2021 (H1N1) virus.
Phase: PHASE2 • Sponsor: Traws Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Personalized blood pressure after stroke could boost recovery
Disease control Not yet recruitingThe RESCUE-BP is a multi-centered, prospective, randomized, open label, blinded endpoint (PROBE) phase III trial. In patients with acute ischemic stroke who have undergone endovascular treatment and achieved successful recanalization, the evaluation will compare a stratified bloo…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can simulated High-Altitude breathing boost lung cancer treatment?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if adding intermittent hypoxic training (IHT) to standard neoadjuvant chemo-immunotherapy can increase the pathologic complete response (pCR) rate in patients aged 18 to 75 of both sexes with resectable stage II-IIIA lung squamous cell …
Phase: PHASE2 • Sponsor: zhang yi • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a breast cancer drug treat ectopic pregnancy?
Disease control Not yet recruitingThe aim of work is to study the effectiveness of letrozole in treatment of early undisturbed ectopic pregnancy in comparison with Methotrexate.
Phase: PHASE2 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could AR games beat the patch? new study tests lazy eye treatment in teens and adults
Symptom relief Not yet recruitingThe goal of this clinical trial is to investigate the efficacy and safety of dichoptic treatment based on Augmented Reality (AR) technology in treating monocular amblyopia aged 12 to 55 years, and compare dichoptic AR treatment with the standard patching therapy. The main questio…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can an ancient herbal remedy tame rheumatoid arthritis?
Disease control Not yet recruitingRheumatoid Arthritis (RA) is a chronic disease characterised by symmetric, polyarticular pain and swelling, involving small joints of the hands and feet. RA can lead to irreversible joint damage without treatment, causing disability and impacting daily activities and work product…
Phase: PHASE2, PHASE3 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New combo aims to stop bleeding in bone marrow disease
Disease control Not yet recruitingThis study aims to compare the efficacy and safety of recombinant human thrombopoietin (rhTPO) + cyclosporine (CsA) and CsA monotherapy in the treatment of lower-risk myelodysplastic neoplasms with thrombocytopenia.
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Pee power: simple urine test could revolutionize heart failure care
Disease control Not yet recruitingThe SURE-HF trial is a pragmatic, multicentre, randomized controlled study evaluating natriuresis-guided optimization of intravenous loop diuretic therapy in patients hospitalized with worsening heart failure (WHF). The study aims to determine whether serial urinary sodium assess…
Phase: NA • Sponsor: Nurgul Ablakimova • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Acupuncture timing may be key to preventing dry mouth in head and neck cancer patients
Symptom relief Not yet recruitingWhile existing data supports the use of acupuncture to reduce radiation-induced xerostomia, the optimal timing of acupuncture for managing chemoradiation-induced xerostomia remains an area of active investigation. Prior studies have administered acupuncture either in patients who…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could a simple infusion during surgery stop pain before it starts?
Symptom relief Not yet recruitingThe development of chronic postoperative pain (CPP) following surgery is influenced by several factors, among which the intensity of acute postoperative pain in the immediate perioperative period and mechanisms related to nerve fiber injury play a crucial role. Previous studies h…
Phase: NA • Sponsor: Centre of Postgraduate Medical Education • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC